Medsintez Plant presents innovative dosing devices at the Product Innovation Fair in Moscow.

Medsintez Plant participated in a key industry event, Product Innovation Fair in Medicine and Healthcare, which took place in Moscow on October 29–30. Viktor Fisenko, First Deputy Minister of Healthcare of Russia, attended the exhibition of domestic innovations in the field of drugs and medical products.

«We are interested in ensuring that the rights to domestic innovations remain in our country and benefit the people,» said Viktor Fisenko. The accumulated experience confirms that Russia is able to accelerate the development of high-tech products in accordance with national standards. Viktor Fisenko noted that this area of development is directly associated with strategic national goals focused on technological leadership.

At the exhibition of domestic innovations, Medsintez Plant presented a line of its own innovations—disposable and reusable injection pens, as well as autoinjectors. These devices are designed for the precise and comfortable administration of a wide range of drugs, including those for the treatment of diabetes: insulins, GLP-1 agents (Semaglutide, Liraglutide, Dulaglutide, Tirzepatide), as well as for the treatment of infertility: FSH, HCG, Cetrorelix, etc.

These patented injection pens allow for highly accurate dosing. The plant possesses a unique technology that allows it to design devices for administering any dose—from a few microliters to 0.5 mL.

The use of pre-filled injection pens and autoinjectors solves several important problems for the patient: it makes injections simple and comfortable, ensures highly accurate administration of even small doses, eliminates errors caused by the wear of devices, and promotes strict adherence to the prescribed treatment regimen.

A special presentation was given for the reusable injection pen for administering Rosinsulin in cartridges. The device is equipped with a unique patented mechanism to return an incorrectly set dose. Scale division value: 1 unit, 60 units per injection pen.

Participation in the Product Innovation Fair proved the leading position of Medsintez Plant in the development of innovative medical technologies and contributed to promoting the cooperation between research institutions and industry partners. The company continues working on improvement of the quality of life of patients and develops domestic production of critical medical devices.